Yangfeng Wu, Professor and Doctoral Supervisor. Currently serves as the Deputy Dean of the Institute of Advanced Clinical Medicine at Peking University, enjoys the State Council's government allowance, and has been selected for the national "New Century Hundred, Thousand, Ten Thousand Talents Project". He has successively presided over dozens of scientific research projects, including the National Science and Technology Key Project, Science and Technology Support Plan, Key Research and Development Plan, and the National Natural Science Foundation. He has published over 440 papers in domestic and international medical journals such as NEJM, Lancet, JAMA, BMJ, and Nature Medicine, and has edited and co-edited 21 monographs in Chinese and English. He has led the development of China's first cardiovascular disease risk prediction model and has chaired the formulation of the "Practical Guidelines for Primary Hypertension Prevention and Treatment" and the "Chinese Low-Sodium Salt Promotion and Application Guidelines". He has received numerous honors, including the Ministry of Health Science and Technology Progress Award, Chinese Medical Science and Technology Progress Award, Beijing Science and Technology Progress Award, Wu Jie Ping Medical Research Award - Paul Janssen Pharmaceutical Award, and many others. He has served as the Director of the World Health Organization's Cardiovascular Disease Training and Cooperation Center, the Director of the The George Institute for Global Health, China and an Honorary Professor at the University of Sydney's Faculty of Medicine. Currently, he holds positions such as the Chair of the Health Risk Assessment and Control Committee of the Chinese Preventive Medicine Association and the Chair of the Beijing Investigator-initiated Clinical Research Standardization Management Expert Committee. Both "Career Impact" and "Annual Impact" have been selected for Elsevier's list of the top 2% of global scientists. His current main research direction is the effective screening and prevention and control measures for major chronic diseases.